In a peanut allergy model, animals treated with CTLA-4Ig, anti-CD86, or anti-CD80 plus anti-CD86 achieved successful oral tolerance, but those treated with anti-CD80 were compromised [112]. The gene discussed is CD86; the disease is peanut allergic reaction.